Trial Profile
C-Cure - Safety, Feasibility and Efficacy of Guided Bone Marrow-derived Mesenchymal Cardiopoietic Cells for the Treatment of Heart Failure Secondary to Ischemic Cardiomyopathy
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 22 Jun 2020
Price :
$35
*
At a glance
- Drugs C3BS CQR 1 (Primary)
- Indications Cardiomyopathies; Chronic heart failure; Ischaemic heart disorders
- Focus Therapeutic Use
- Acronyms C-CURE
- Sponsors Cardio3 BioSciences
- 11 Apr 2013 Phase II results have been published in the on-line edition of the Journal of the American College of Cardiology (JACC), according to a Cardio3 BioSciences media release.
- 07 Nov 2011 New source identified and integrated (ical Trials Registry - India: CTRI2011-05-001742).
- 31 Aug 2011 Results presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.